SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
7751880
Source:
http://linkedlifedata.com/resource/pubmed/id/7751880
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0032854
,
umls-concept:C0035020
,
umls-concept:C0087111
,
umls-concept:C0205087
,
umls-concept:C0349644
,
umls-concept:C1274040
,
umls-concept:C1561558
pubmed:issue
6
pubmed:dateCreated
1995-6-22
pubmed:abstractText
To determine the significance of the International Prognostic Index (IPI) score in adults with testicular lymphoma treated with doxorubicin-based regimens.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA16672
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin
,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone
,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0732-183X
pubmed:author
pubmed-author:CabanillasFF
,
pubmed-author:CoxJJ
,
pubmed-author:DimopoulosM AMA
,
pubmed-author:HessMM
,
pubmed-author:PughWW
,
pubmed-author:SarrisA HAH
,
pubmed-author:TouroutoglouNN
,
pubmed-author:YounesAA
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1361-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:7751880-Adult
,
pubmed-meshheading:7751880-Aged
,
pubmed-meshheading:7751880-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:7751880-Cyclophosphamide
,
pubmed-meshheading:7751880-Doxorubicin
,
pubmed-meshheading:7751880-Humans
,
pubmed-meshheading:7751880-Lymphoma, Large B-Cell, Diffuse
,
pubmed-meshheading:7751880-Lymphoma, Non-Hodgkin
,
pubmed-meshheading:7751880-Male
,
pubmed-meshheading:7751880-Middle Aged
,
pubmed-meshheading:7751880-Neoplasm Staging
,
pubmed-meshheading:7751880-Orchiectomy
,
pubmed-meshheading:7751880-Prednisone
,
pubmed-meshheading:7751880-Recurrence
,
pubmed-meshheading:7751880-Remission Induction
,
pubmed-meshheading:7751880-Retrospective Studies
,
pubmed-meshheading:7751880-Salvage Therapy
,
pubmed-meshheading:7751880-Survival Rate
,
pubmed-meshheading:7751880-Testicular Neoplasms
,
pubmed-meshheading:7751880-Treatment Failure
,
pubmed-meshheading:7751880-Vincristine
pubmed:year
1995
pubmed:articleTitle
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
pubmed:affiliation
Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston, USA.
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, P.H.S.